Developer docs
API playgroundTry for free, no card

Search company profiles

Macter

Full company profile

uuid000e6yv

Namestring
Macter
Legal namestring
Macter International Limited
Websiteurl
macter.com
Company typeenum
Public
Founded yearint
1980
Descriptiontext

Macter International Limited is a publicly listed Pakistani pharmaceutical manufacturer headquartered in Karachi and traded on the Pakistan Stock Exchange under the ticker MACTER. The company produces pharmaceutical, biological, and consumer health products across antibiotics, anti-diabetics, anti-ulcerants, anti-virals, anti-epileptics, oncology, nephrology, vaccines, probiotics, vitamins, supplements, and over-the-counter medications, organized across three product categories — Pharmaceutical, Biological, and Consumer. Operationally, Macter runs a manufacturing capacity of approximately 1 billion tablets per year with state-of-the-art biotech and sterile facilities, ISO-aligned Quality Management, Environmental, and Occupational Health & Safety Management Systems, and a microbiology laboratory supporting sterility, microbial limit, bacterial endotoxin, and water testing. The business model combines contract manufacturing for world-leading multinational healthcare companies — where Macter is positioned as the largest such contract manufacturer in Pakistan — with branded sales of its own portfolio across a domestic distribution network and exports to 16 countries. Commercial reach is sustained by a 400+ field force running Continuous Medical Education programs, ward presentations, local speaker programs, and KOL focus groups across diabetes, cardiology, pulmonology, virology, hepatology, and orthopedics, supplemented by corporate social responsibility programs including Hepatitis B vaccination partnerships.

Short descriptiontext

Macter International Limited is a publicly listed Pakistani pharmaceutical manufacturer headquartered in Karachi that produces branded pharmaceutical, biological, and consumer health products and operates as the largest contract manufacturer for world-leading healthcare companies in Pakistan, exporting to 16 countries with capacity of 1 billion tablets per year.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersKarachi, Pakistan
HQ citystring
Karachi
HQ countrystring
Pakistan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, contract manufacturing, biological products, consumer health products, generic medicines
Industry1 code
PRIMARYTLAIAGAI
Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs)
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing32541
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Manufacturing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Contract Manufacturing
TypeManaged Services
Description

Manufacturing pharmaceutical products for world leading healthcare companies as the largest contract manufacturer in Pakistan

macter.com
2Pharmaceutical Products Sales
TypeOne Time License
Description

Sale of branded pharmaceutical products including antibiotics, anti-diabetics, cardiovascular drugs, and anti-cancer medications

macter.com
3Biological Products Sales
TypeOne Time License
Description

Sale of biological products including vaccines, probiotics, and biotech medications

macter.com
4Consumer Products Sales
TypeOne Time License
Description

Sale of consumer health products including vitamins, supplements, and over-the-counter medications

macter.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Macter International Limited manufactures and markets pharmaceutical, biological, and consumer health products, and operates as the largest contract manufacturer in Pakistan for world-leading healthcare companies. The company produces over 1 billion tablets annually across therapeutic categories including antibiotics, anti-diabetics, cardiovascular, anti-cancer, anti-virals, anti-epileptics, and biologics such as GLP-1 receptor agonists and anti-TNF agents, exporting to 16 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 1 billion tablets manufactured per year
+3 more records
Product overview1 text field

Macter International Limited is a Pakistani pharmaceutical company serving as a contract manufacturer for world-leading healthcare companies. The company operates with three main product categories: Pharmaceutical Products (antibiotics, anti-diabetics, anti-ulcerants, anti-virals, anti-epileptics, and specialty medicines in tablet, capsule, syrup, injection, and infusion forms), Biological Products (GLP-1 receptor agonists like TirzaTrim and Seglu, anti-TNF agents like Fliximac, and other biologic therapies), and Consumer Products (vitamin D supplements like DX3 and calcium supplements like Avelia). With manufacturing capacity exceeding 1 billion tablets annually and presence across 16 countries, Macter offers both contract manufacturing services and branded pharmaceutical products through its distribution network.

Product and service28 records
1TirzaTrim
CategoryBiological
Description

Tirzepatide-based multi-dose pre-filled pen for glycemic control in adults and children aged 10+ with type 2 diabetes and for weight management in adults with obesity or overweight with weight-related comorbidities.

2Xelvira
CategoryPharmaceutical
Description

Capecitabine 500mg tablets for treatment of multiple solid tumors including colorectal, breast, gastric, esophageal, gastroesophageal junction, and pancreatic cancers.

3Seglu
CategoryBiological
Description

Semaglutide GLP-1 receptor agonist pre-filled syringe for cardiovascular risk reduction, glycemic control, renal protection, weight management, and noncirrhotic MASH treatment.

4Fliximac
CategoryBiological
Description

Infliximab 100mg anti-TNF agent as lyophilized powder for infusion for treatment of rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, plaque psoriasis, and ulcerative colitis.

5Dafrova
CategoryBiological
Description

Daprodustat tablets (2mg, 4mg, 6mg) for treatment of anaemia due to chronic kidney disease in adults who have been receiving dialysis for at least four months.

6Adalin
CategoryPharmaceutical
Description

Cough syrup (32mg+8mg+30mg+0.98mg per ml) for symptomatic treatment of productive cough, allergic cough, smoker's cough, dry irritating cough, and acute/chronic bronchitis.

7Atizox
CategoryPharmaceutical
Description

Nitazoxanide 500mg tablets and 100mg/5ml suspension for treatment of diarrhea due to intestinal parasitic infections (Cryptosporidium parvum and Giardia lamblia).

8Bismol
CategoryPharmaceutical
Description

Bismuth-based product (265mg tablets, 88mg/5ml suspension) for upset stomach, indigestion, heartburn, nausea, and diarrhea control.

9Co-Amoxi
CategoryPharmaceutical
Description

Amoxicillin + Clavulanic Acid antibiotic in tablets, suspension, BD suspension, injection, and drops for respiratory tract infections, otitis media, sinusitis, skin infections, and UTIs.

10Clavox
CategoryPharmaceutical
Description

Amoxicillin antibiotic in 250mg, 500mg, and 1000mg vials for treatment of lower respiratory tract infections, genitourinary infections, gynecologic infections, bacteremia/septicemia, skin infections, and intra-abdominal infections.

11Mclevo
CategoryPharmaceutical
Description

Levofloxacin antibiotic in 250mg, 500mg, and 750mg tablets for treatment of bacterial infections including pneumonia, chronic bronchitis, sinusitis, urinary tract infections, and skin infections.

12Ciproquine
CategoryPharmaceutical
Description

Ciprofloxacin antibiotic in 250mg, 500mg tablets and 200mg/100ml infusion for urinary tract infections, respiratory infections, skin infections, bone and joint infections, infectious diarrhea, and typhoid fever.

13Itoguard
CategoryPharmaceutical
Description

Itopride hydrochloride 50mg tablets and 150mg OD capsules for treatment of gastrointestinal symptoms of functional dyspepsia including bloating, early satiety, upper abdominal pain, anorexia, heartburn, nausea, and vomiting.

14Esante
CategoryPharmaceutical
Description

Esomeprazole 20mg and 40mg capsules for treatment of GERD, healing of erosive esophagitis, NSAID-associated gastric ulcer risk reduction, and H. pylori eradication.

15Avelia Tablets
CategoryConsumer
Description

Calcium supplement (400 I.U. Vitamin D + 90 mcg Vitamin K + 500 mg calcium) for prevention and treatment of osteoporosis, pregnancy/lactation calcium needs, and bone mineral density improvement.

16Ecavir
CategoryPharmaceutical
Description

Entecavir 0.5mg tablets for treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and persistent elevations in serum aminotransferases.

17Epilepsin
CategoryPharmaceutical
Description

Carbamazepine 200mg tablets for treatment of partial seizures with complex symptomatology, generalized tonic-clonic seizures, mixed seizure patterns, and trigeminal neuralgia.

18Glio
CategoryPharmaceutical
Description

Glimepiride 1mg, 2mg, 3mg, 4mg tablets as adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus.

19Tacip
CategoryPharmaceutical
Description

Piperacillin + Tazobactam 2.25g and 4.5g powder for injection for treatment of intra-abdominal infections, skin infections, urinary tract infections, pneumonia, bacterial septicemia, and bone/joint infections.

20Tio-Veez
CategoryPharmaceutical
Description

Tiotropium bromide 18mcg capsules for long-term once-daily maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.

21Epuram
CategoryConsumer
Description

Amino acid supplement containing L-Arginine + L-Citrulline + L-Ornithine in tablet, injection, and suspension forms for nutritional supplementation.

22Vireof
CategoryPharmaceutical
Description

Tenofovir Disoproxil Fumarate 300mg tablets for treatment of chronic hepatitis B in adults and pediatric patients 12+ and HIV-1 infection in combination with other antiretroviral agents.

23Titan
CategoryPharmaceutical
Description

Ceftriaxone antibiotic in 250mg, 500mg, 1000mg, 2000mg for treatment of lower respiratory tract infections, otitis media, skin infections, urinary tract infections, gonorrhea, pelvic inflammatory diseases, bone/joint infections, and meningitis.

24DX3 Softgel
CategoryConsumer
Description

Vitamin D 50,000 I.U. softgel capsules for treatment of refractory rickets, familial hypophosphatemia, hypoparathyroidism, hypocalcemia, renal osteodystrophy, and osteoporosis management.

25Silo
CategoryPharmaceutical
Description

Sitagliptin 50mg and 100mg tablets as adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus.

26Maxima
CategoryPharmaceutical
Description

Cefixime antibiotic in tablets (200mg), capsules (400mg), and dry suspensions for treatment of urinary tract infections, otitis media, pharyngitis, tonsillitis, acute exacerbations of chronic bronchitis, and uncomplicated gonorrhea.

27Mactifen
CategoryPharmaceutical
Description

Cetirizine 1mg tablets and syrup for symptomatic treatment of allergic conditions including rhinitis and conjunctivitis.

28Contract Manufacturing Services
CategoryManufacturing Services
Description

Contract manufacturing services for world-leading healthcare companies in Pakistan; the largest contract manufacturer in Pakistan providing pharmaceutical, biological, and consumer product manufacturing at scale of 1 billion tablets per year.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1F.D. Registrar Services (SMC-Pvt) Ltd
Strategic tierSupportTypeOthers
Description

Share registrar services provider for Macter's stock exchange operations. Located at 17th Floor, Saima Trade Tower A, I.I. Chundrigar Road Karachi.

macter.com
2Various NGOs
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Macter has partnered with various NGOs for Hepatitis B vaccination campaigns across Pakistan, including programs from 2002-2008 that reached large populations at 50% cost.

3World Leading Healthcare Companies
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Macter serves as the largest contract manufacturer for world leading healthcare companies in Pakistan, providing pharmaceutical manufacturing services.

macter.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pakistani pharma group with branded generics and contract manufacturing; competes with Macter in the same domestic therapeutic areas and in international tenders.

TypeDirect peer
Description

Pakistani pharmaceutical manufacturer with branded generics, biologics and contract manufacturing; the most direct local comparable to Macter across therapeutic categories and export footprint.

3The Searle Company
TypeDirect peer
Description

PSX-listed Pakistani pharma with branded generics, manufacturing and 16+ country export operations; competes directly with Macter in cardiology, diabetes, and contract manufacturing.

TypeDirect peer
Description

Pakistani pharma manufacturer across antibiotics, cardiology and gastroenterology with branded and contract manufacturing - directly overlapping Macter's small-molecule portfolio.

TypeDirect peer
Description

Pakistani pharmaceutical manufacturer focused on branded generics and licensed products; competes directly with Macter in therapeutic categories such as cardiology and CNS.

TypeDirect peer
Description

PSX-listed Pakistani pharmaceutical company with branded generics and strategic manufacturing partnerships (e.g., Gilead HCV licensing); comparable in scale and product mix.

TypeDirect peer
Description

Pakistani pharmaceutical manufacturer with branded generics, licensing partnerships and export operations; directly comparable to Macter across manufacturing scale and product portfolio.

TypeBroad incumbent
Description

Largest Indian generic and API manufacturer with a global biosimilar pipeline targeting the same molecules as Macter's launches (infliximab, oncology); broader scale but overlapping therapeutic and export ambitions.

TypeBroad incumbent
Description

Major Indian pharma with strong presence in Pakistan and emerging markets; comparable therapeutic mix (anti-infectives, respiratory, diabetes) and global export reach overlapping with Macter's 16-country footprint.

10Renata Limited
TypeRegional player
Description

Bangladesh's largest pharmaceutical company (also listed on its domestic exchanges) with branded generics, biologics and animal health; comparable in scale, regulatory strategy and emerging-market export model to Macter.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Macter

Pharmaceutical Manufacturingmacter.com

Macter International Limited is a publicly listed Pakistani pharmaceutical manufacturer headquartered in Karachi that produces branded pharmaceutical, biological, and consumer health products and operates as the largest contract manufacturer for world-leading healthcare companies in Pakistan, exporting to 16 countries with capacity of 1 billion tablets per year.

What Macter does

Macter International Limited is a publicly listed Pakistani pharmaceutical manufacturer headquartered in Karachi and traded on the Pakistan Stock Exchange under the ticker MACTER. The company produces pharmaceutical, biological, and consumer health products across antibiotics, anti-diabetics, anti-ulcerants, anti-virals, anti-epileptics, oncology, nephrology, vaccines, probiotics, vitamins, supplements, and over-the-counter medications, organized across three product categories — Pharmaceutical, Biological, and Consumer. Operationally, Macter runs a manufacturing capacity of approximately 1 billion tablets per year with state-of-the-art biotech and sterile facilities, ISO-aligned Quality Management, Environmental, and Occupational Health & Safety Management Systems, and a microbiology laboratory supporting sterility, microbial limit, bacterial endotoxin, and water testing. The business model combines contract manufacturing for world-leading multinational healthcare companies — where Macter is positioned as the largest such contract manufacturer in Pakistan — with branded sales of its own portfolio across a domestic distribution network and exports to 16 countries. Commercial reach is sustained by a 400+ field force running Continuous Medical Education programs, ward presentations, local speaker programs, and KOL focus groups across diabetes, cardiology, pulmonology, virology, hepatology, and orthopedics, supplemented by corporate social responsibility programs including Hepatitis B vaccination partnerships.

Macter firmographics

Firmographics
Name
Macter
Legal name
Macter International Limited
Website
https://macter.com
Company type
Public
Founded year
1980
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Macter International Limited is a publicly listed Pakistani pharmaceutical manufacturer headquartered in Karachi that produces branded pharmaceutical, biological, and consumer health products and operates as the largest contract manufacturer for world-leading healthcare companies in Pakistan, exporting to 16 countries with capacity of 1 billion tablets per year.
Ownership category
akta.pro rank

Macter industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYTLAIAGAI
Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs)

Keywords

  • Pharmaceutical manufacturing
  • Contract manufacturing
  • Biological products
  • Consumer health products
  • Generic medicines

Where Macter is headquartered

Location

Headquarters

HQ city
Karachi
HQ country
Pakistan
HQ region
Asia

Offices1 record

Markets served

Macter business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Contract Manufacturing: Manufacturing pharmaceutical products for world leading healthcare companies as the largest contract manufacturer in Pakistan
  2. Pharmaceutical Products Sales: Sale of branded pharmaceutical products including antibiotics, anti-diabetics, cardiovascular drugs, and anti-cancer medications
  3. Biological Products Sales: Sale of biological products including vaccines, probiotics, and biotech medications
  4. Consumer Products Sales: Sale of consumer health products including vitamins, supplements, and over-the-counter medications

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Macter product offering

Product offering

Core offering

Macter International Limited manufactures and markets pharmaceutical, biological, and consumer health products, and operates as the largest contract manufacturer in Pakistan for world-leading healthcare companies. The company produces over 1 billion tablets annually across therapeutic categories including antibiotics, anti-diabetics, cardiovascular, anti-cancer, anti-virals, anti-epileptics, and biologics such as GLP-1 receptor agonists and anti-TNF agents, exporting to 16 countries.

Product overview

Macter International Limited is a Pakistani pharmaceutical company serving as a contract manufacturer for world-leading healthcare companies. The company operates with three main product categories: Pharmaceutical Products (antibiotics, anti-diabetics, anti-ulcerants, anti-virals, anti-epileptics, and specialty medicines in tablet, capsule, syrup, injection, and infusion forms), Biological Products (GLP-1 receptor agonists like TirzaTrim and Seglu, anti-TNF agents like Fliximac, and other biologic therapies), and Consumer Products (vitamin D supplements like DX3 and calcium supplements like Avelia). With manufacturing capacity exceeding 1 billion tablets annually and presence across 16 countries, Macter offers both contract manufacturing services and branded pharmaceutical products through its distribution network.

Differentiator

Problem solved

Functional benefit

Products and services

  • TirzaTrim Tirzepatide-based multi-dose pre-filled pen for glycemic control in adults and children aged 10+ with type 2 diabetes and for weight management in adults with obesity or overweight with weight-related comorbidities.
  • Xelvira Capecitabine 500mg tablets for treatment of multiple solid tumors including colorectal, breast, gastric, esophageal, gastroesophageal junction, and pancreatic cancers.
  • Seglu Semaglutide GLP-1 receptor agonist pre-filled syringe for cardiovascular risk reduction, glycemic control, renal protection, weight management, and noncirrhotic MASH treatment.
  • Fliximac Infliximab 100mg anti-TNF agent as lyophilized powder for infusion for treatment of rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, plaque psoriasis, and ulcerative colitis.
  • Dafrova Daprodustat tablets (2mg, 4mg, 6mg) for treatment of anaemia due to chronic kidney disease in adults who have been receiving dialysis for at least four months.
  • Adalin Cough syrup (32mg+8mg+30mg+0.98mg per ml) for symptomatic treatment of productive cough, allergic cough, smoker's cough, dry irritating cough, and acute/chronic bronchitis.
  • Atizox Nitazoxanide 500mg tablets and 100mg/5ml suspension for treatment of diarrhea due to intestinal parasitic infections (Cryptosporidium parvum and Giardia lamblia).
  • Bismol Bismuth-based product (265mg tablets, 88mg/5ml suspension) for upset stomach, indigestion, heartburn, nausea, and diarrhea control.
  • Co-Amoxi Amoxicillin + Clavulanic Acid antibiotic in tablets, suspension, BD suspension, injection, and drops for respiratory tract infections, otitis media, sinusitis, skin infections, and UTIs.
  • Clavox Amoxicillin antibiotic in 250mg, 500mg, and 1000mg vials for treatment of lower respiratory tract infections, genitourinary infections, gynecologic infections, bacteremia/septicemia, skin infections, and intra-abdominal infections.
  • Mclevo Levofloxacin antibiotic in 250mg, 500mg, and 750mg tablets for treatment of bacterial infections including pneumonia, chronic bronchitis, sinusitis, urinary tract infections, and skin infections.
  • Ciproquine Ciprofloxacin antibiotic in 250mg, 500mg tablets and 200mg/100ml infusion for urinary tract infections, respiratory infections, skin infections, bone and joint infections, infectious diarrhea, and typhoid fever.
  • Itoguard Itopride hydrochloride 50mg tablets and 150mg OD capsules for treatment of gastrointestinal symptoms of functional dyspepsia including bloating, early satiety, upper abdominal pain, anorexia, heartburn, nausea, and vomiting.
  • Esante Esomeprazole 20mg and 40mg capsules for treatment of GERD, healing of erosive esophagitis, NSAID-associated gastric ulcer risk reduction, and H. pylori eradication.
  • Avelia Tablets Calcium supplement (400 I.U. Vitamin D + 90 mcg Vitamin K + 500 mg calcium) for prevention and treatment of osteoporosis, pregnancy/lactation calcium needs, and bone mineral density improvement.
  • Ecavir Entecavir 0.5mg tablets for treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and persistent elevations in serum aminotransferases.
  • Epilepsin Carbamazepine 200mg tablets for treatment of partial seizures with complex symptomatology, generalized tonic-clonic seizures, mixed seizure patterns, and trigeminal neuralgia.
  • Glio Glimepiride 1mg, 2mg, 3mg, 4mg tablets as adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus.
  • Tacip Piperacillin + Tazobactam 2.25g and 4.5g powder for injection for treatment of intra-abdominal infections, skin infections, urinary tract infections, pneumonia, bacterial septicemia, and bone/joint infections.
  • Tio-Veez Tiotropium bromide 18mcg capsules for long-term once-daily maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
  • Epuram Amino acid supplement containing L-Arginine + L-Citrulline + L-Ornithine in tablet, injection, and suspension forms for nutritional supplementation.
  • Vireof Tenofovir Disoproxil Fumarate 300mg tablets for treatment of chronic hepatitis B in adults and pediatric patients 12+ and HIV-1 infection in combination with other antiretroviral agents.
  • Titan Ceftriaxone antibiotic in 250mg, 500mg, 1000mg, 2000mg for treatment of lower respiratory tract infections, otitis media, skin infections, urinary tract infections, gonorrhea, pelvic inflammatory diseases, bone/joint infections, and meningitis.
  • DX3 Softgel Vitamin D 50,000 I.U. softgel capsules for treatment of refractory rickets, familial hypophosphatemia, hypoparathyroidism, hypocalcemia, renal osteodystrophy, and osteoporosis management.
  • Silo Sitagliptin 50mg and 100mg tablets as adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus.
  • Maxima Cefixime antibiotic in tablets (200mg), capsules (400mg), and dry suspensions for treatment of urinary tract infections, otitis media, pharyngitis, tonsillitis, acute exacerbations of chronic bronchitis, and uncomplicated gonorrhea.
  • Mactifen Cetirizine 1mg tablets and syrup for symptomatic treatment of allergic conditions including rhinitis and conjunctivitis.
  • Contract Manufacturing Services Contract manufacturing services for world-leading healthcare companies in Pakistan; the largest contract manufacturer in Pakistan providing pharmaceutical, biological, and consumer product manufacturing at scale of 1 billion tablets per year.

Quantifiable outcome

  • 1 billion tablets manufactured per year
  • +3 more outcomes

Companies that use Macter

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Macter technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Macter partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered support, minor and core.

  • F.D. Registrar Services (SMC-Pvt) LtdsupportOthersShare registrar services provider for Macter's stock exchange operations. Located at 17th Floor, Saima Trade Tower A, I.I. Chundrigar Road Karachi.
  • Various NGOsminorStrategic or Co-development PartnerMacter has partnered with various NGOs for Hepatitis B vaccination campaigns across Pakistan, including programs from 2002-2008 that reached large populations at 50% cost.
  • World Leading Healthcare CompaniescoreChannel Partner/ Reseller/ DistributorMacter serves as the largest contract manufacturer for world leading healthcare companies in Pakistan, providing pharmaceutical manufacturing services.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Macter competitors and assessment

Company assessment

Direct peers

  • OBS Pakistan (Obsons Group): Pakistani pharma group with branded generics and contract manufacturing; competes with Macter in the same domestic therapeutic areas and in international tenders.
  • Getz Pharma: Pakistani pharmaceutical manufacturer with branded generics, biologics and contract manufacturing; the most direct local comparable to Macter across therapeutic categories and export footprint.
  • The Searle Company: PSX-listed Pakistani pharma with branded generics, manufacturing and 16+ country export operations; competes directly with Macter in cardiology, diabetes, and contract manufacturing.
  • Hilton Pharma: Pakistani pharma manufacturer across antibiotics, cardiology and gastroenterology with branded and contract manufacturing - directly overlapping Macter's small-molecule portfolio.
  • AGP Limited: Pakistani pharmaceutical manufacturer focused on branded generics and licensed products; competes directly with Macter in therapeutic categories such as cardiology and CNS.
  • Ferozsons Laboratories: PSX-listed Pakistani pharmaceutical company with branded generics and strategic manufacturing partnerships (e.g., Gilead HCV licensing); comparable in scale and product mix.
  • CCL Pharmaceuticals: Pakistani pharmaceutical manufacturer with branded generics, licensing partnerships and export operations; directly comparable to Macter across manufacturing scale and product portfolio.

Broad incumbents

  • Aurobindo Pharma: Largest Indian generic and API manufacturer with a global biosimilar pipeline targeting the same molecules as Macter's launches (infliximab, oncology); broader scale but overlapping therapeutic and export ambitions.
  • Cipla: Major Indian pharma with strong presence in Pakistan and emerging markets; comparable therapeutic mix (anti-infectives, respiratory, diabetes) and global export reach overlapping with Macter's 16-country footprint.

Regional players

  • Renata Limited: Bangladesh's largest pharmaceutical company (also listed on its domestic exchanges) with branded generics, biologics and animal health; comparable in scale, regulatory strategy and emerging-market export model to Macter.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Macter social profiles

Digital presence

Macter financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Macter leadership team

Management profile

Number of profiles

Profiles1 record

Macter funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Macter M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Macter

What does Macter do?

Macter International Limited manufactures and markets pharmaceutical, biological, and consumer health products, and operates as the largest contract manufacturer in Pakistan for world-leading healthcare companies. The company produces over 1 billion tablets annually across therapeutic categories including antibiotics, anti-diabetics, cardiovascular, anti-cancer, anti-virals, anti-epileptics, and biologics such as GLP-1 receptor agonists and anti-TNF agents, exporting to 16 countries.

Is Macter a public or private company?

Macter is a public company. It is classified as public and is currently operating.

When was Macter founded?

Macter was founded in 1980. It employs 1,001 to 5,000 people.

Where is Macter based?

Macter is headquartered in Karachi, Pakistan, in the Asia region.

How does Macter make money?

Four revenue lines are on record. Contract Manufacturing is the primary driver. The others are pharmaceutical Products Sales, biological Products Sales and consumer Products Sales.

Who are Macter's main competitors?

Direct peers on record are OBS Pakistan (Obsons Group), Getz Pharma, The Searle Company, Hilton Pharma, AGP Limited, Ferozsons Laboratories and CCL Pharmaceuticals. Broad incumbents are Aurobindo Pharma and Cipla. Renata Limited is listed as a regional player.

Does Macter have an API?

No public API is recorded for Macter.

What industry is Macter in?

Macter's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is TLAIAGAI, Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals